NO311328B1 - Farmasöytisk blanding, anvendelse derav samt pregnan- eller cholanforbindelser - Google Patents

Farmasöytisk blanding, anvendelse derav samt pregnan- eller cholanforbindelser Download PDF

Info

Publication number
NO311328B1
NO311328B1 NO19970472A NO970472A NO311328B1 NO 311328 B1 NO311328 B1 NO 311328B1 NO 19970472 A NO19970472 A NO 19970472A NO 970472 A NO970472 A NO 970472A NO 311328 B1 NO311328 B1 NO 311328B1
Authority
NO
Norway
Prior art keywords
pregna
dien
trien
chola
dione
Prior art date
Application number
NO19970472A
Other languages
English (en)
Norwegian (no)
Other versions
NO970472L (no
NO970472D0 (no
Inventor
Clive L Jennings-White
David L Berliner
Nathan William Adams
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/286,073 external-priority patent/US5563131A/en
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of NO970472D0 publication Critical patent/NO970472D0/no
Publication of NO970472L publication Critical patent/NO970472L/no
Publication of NO311328B1 publication Critical patent/NO311328B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19970472A 1994-08-04 1997-02-03 Farmasöytisk blanding, anvendelse derav samt pregnan- eller cholanforbindelser NO311328B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/286,073 US5563131A (en) 1994-08-04 1994-08-04 Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US08/510,957 US5994333A (en) 1994-08-04 1995-08-03 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PCT/US1995/009634 WO1996004296A1 (en) 1994-08-04 1995-08-04 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function

Publications (3)

Publication Number Publication Date
NO970472D0 NO970472D0 (no) 1997-02-03
NO970472L NO970472L (no) 1997-04-03
NO311328B1 true NO311328B1 (no) 2001-11-19

Family

ID=26963568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970472A NO311328B1 (no) 1994-08-04 1997-02-03 Farmasöytisk blanding, anvendelse derav samt pregnan- eller cholanforbindelser

Country Status (11)

Country Link
US (1) US5994333A (cs)
EP (1) EP0775154A4 (cs)
CN (1) CN1173181A (cs)
BR (1) BR9508519A (cs)
CA (1) CA2196690C (cs)
CZ (1) CZ32997A3 (cs)
FI (1) FI970447L (cs)
MX (1) MX9700881A (cs)
NO (1) NO311328B1 (cs)
NZ (1) NZ291056A (cs)
PL (1) PL318521A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
WO2009039103A2 (en) * 2007-09-17 2009-03-26 Human Pheromone Sciences, Inc. Fragrance compositions and other compositions which contain naturally occurring substances found in corals
EP2278880B1 (en) 2008-04-09 2012-10-10 Pherin Pharmaceuticals, Inc. Steroid treatment for hot flashes
EP2938346B1 (en) * 2012-12-28 2017-04-05 Pherin Pharmaceuticals, Inc. Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders
CN114128658B (zh) * 2021-11-25 2023-03-24 中国水产科学研究院黑龙江水产研究所 一种用于人工鱼巢的改性椰丝材料的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
DE69435286D1 (de) * 1993-05-24 2010-05-20 Purdue Pharma Ltd Verfahren und zusammensetzungen zum hervorrufen von schlaf
ES2210242T3 (es) * 1993-06-15 2004-07-01 Pherin Pharmaceuticals, Inc. Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana y composiciones farmaceuticas relacionadas.
HUT74172A (en) * 1993-06-15 1996-11-28 Pherin Corp Androstane steroids as neurochemical initilators of change in human hypothalamic function and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ291056A (en) 2001-03-30
FI970447A7 (fi) 1997-04-03
FI970447A0 (fi) 1997-02-03
CZ32997A3 (en) 1997-09-17
NO970472L (no) 1997-04-03
PL318521A1 (en) 1997-06-23
FI970447L (fi) 1997-04-03
EP0775154A4 (en) 2001-05-09
US5994333A (en) 1999-11-30
BR9508519A (pt) 1998-07-14
CA2196690C (en) 2008-01-08
CN1173181A (zh) 1998-02-11
EP0775154A1 (en) 1997-05-28
NO970472D0 (no) 1997-02-03
CA2196690A1 (en) 1996-02-15
MX9700881A (es) 1997-04-30

Similar Documents

Publication Publication Date Title
AU703524B2 (en) Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
EP0830369B1 (en) Nor-pregnanes for inducing hypothalamic effects
WO1996040727A9 (en) Novel nor-pregnanes for inducing hypothalamic effects
US6331534B1 (en) Steroids as neurochemical stimulators of the VNO to alleviate pain
AU735804B2 (en) Steroids as neurochemical initiators of change in human blood levels of LH or FSH
WO1998014194A9 (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of anxiety
WO1998014194A1 (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of anxiety
WO1997036596A9 (en) Steroids as neurochemical initiators of change in human blood levels of lh or fsh
CA2165325A1 (en) Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
EP0715517B1 (en) Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
JP4450435B2 (ja) Ｐｍｓおよび不安の症状を緩和する、ｖｎｏにおける神経化学刺激物質としてのステロイド
WO1997046574A9 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
EP0783512A4 (en) NOVEL ANDROSTANES FOR INDUCING HYPOTHALAMIC EFFECTS
AU705422B2 (en) Novel estrenes for inducing hypothalamic effects
WO1998003207A9 (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
US6352980B1 (en) Estrenes for inducting hypothalamic effects
NO311328B1 (no) Farmasöytisk blanding, anvendelse derav samt pregnan- eller cholanforbindelser
US5633392A (en) Estrenes for inducing hypothalamic effects
HK1018068A (en) Novel estrenes for inducing hypothalamic effects
MXPA98007951A (en) Steroids as neurochemical initiators of change in the levels in human blood of luteinizing hormone or stimulating hormone of folicu
MXPA99000885A (en) Steroids as neurochemical stimulants of the vomeronasal organ for mitigating symptoms of the pre-menstrual syndrome and ansie

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003